Navigation Links
Synchrotron radiation illuminates how babies' protective bubble bursts

Researchers at the University of Reading, School of Pharmacy have developed an important new technique to study one of the most common causes of premature birth and prenatal mortality. The findings are published in the November 7 issue of the online, open-access journal PLoS ONE.

Dr Che Connon, a Research Councils UK Fellow in Stem Cells and Nanomaterials, and his team used a powerful X-ray beam to examine tiny structures within the protective sac - amniotic membrane - which surrounds the developing baby.

This beam can resolve structures far smaller than a light or electron microscope. Furthermore, unlike other more intrusive forms of microscopy, X-ray investigation requires no processing of the tissue before examination, so can produce an accurate measurement of amniotic membrane structure in its normal state.

When the protective sac raptures during labour this is when the mothers waters burst; if premature rupture occurs it can result in death or mental retardation of the child. Currently premature birth is increasing and 40% are attributed to the early rupture of amniotic membranes. Thus, a better understanding of the rupture process will lead to better treatment, earlier diagnosis and fewer premature deliveries

Dr Connon, an expert in tissue structure, said: This is of interest to the general public because amniotic membrane rupture is an important stage in the start of labour. More importantly early rupture of the amniotic membranes occurs in up to 20% of all pregnancies worldwide, and is the most common cause of preterm birth, leading to babies dying or having major problems such as cerebral palsy. The paper describes a new breakthrough in understanding the structure of amniotic membranes and how they rupture. Hopefully this will lead to therapies designed to prevent preterm membrane rupture as well.

Rupture of amniotic sac has been associated with a weakening of the tissue, but there is very little information available concerning the detailed mechanics of how this actually occurs.

We have now identified a regular cross-work arrangement of fibre forming molecules within the amniotic membrane which give the tissue its strength. Furthermore we have detected nanoscale alterations in the molecular arrangement within areas associated with amniotic membrane rupture. These results suggest, for the first time, that it is the loss of this molecular lattice like arrangement that governs the timing of membranes rupture.

Therefore, by controlling the amniotic membranes molecular arrangement we believe we can prevent premature rupture and delivery in the future.


Contact: Che Connon
Public Library of Science

Related biology technology :

1. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
3. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
4. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
5. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:10/29/2015)... , Oct. 29, 2015   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... Tech Association (MHTA) as one of only three finalists ... "Software – Small and Growing" category. The Tekne Awards honor ... have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):